Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops a combination drug of levocetirizine and montelukast to treat inflammation caused by conditions like influenza. Their pharmaceutical product aims to help patients recover from inflammatory disorders.